choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Ezetimibe

Ezetimibe Newsletter
  • Blood pressure pills RECALLED due to manufacturing mix-up 20 Dec 2025 02:36 GMT

    … often outperform contaminated pharmaceuticals, which increasingly … exactly what your doctor prescribed – nothing … medication recalls affecting blood pressure, cholesterol or heart disease drugsezetimibe in their blood pressure pills? According to the FDA

  • FDA approves Lerochol as monthly PCSK9 inhibitor for hypercholesterolemia 17 Dec 2025 17:51 GMT

    The FDA has approved LIB Therapeutics’ … LDL-C targets. The drug also lowered apolipoprotein B by … tolerated, and showed no treatment-related serious adverse events, … C reduction. Despite current treatments with statins, ezetimibe, and existing PCSK9 inhibitors …

  • Seven million warned over fruit as expert highlights potentially dangerous statin side effects 17 Dec 2025 11:04 GMT

    … were given cholesterol-busting statins or ezetimibe in 2023/3 … intake for patients on such treatments. Writing in The Conversation, … drugs, it's best to talk to your doctor … key medication (Image: Getty) Why are people prescribed statins? Statins help …

  • <![CDATA[Expanding Options for Statin-Intolerant Patients with ASCVD]]> 16 Dec 2025 19:17 GMT

    … on management strategies for statin-intolerant patients with ASCVD … range of non-statin options, including ezetimibe, PCSK9 inhibitors, … that inclisiran’s updated FDA indication now allows its … event reduction benefits in statin-intolerant populations. The …

  • FDA approves monthly PCSK9 inhibitor for high cholesterol 15 Dec 2025 16:49 GMT

    … already taking a statin and ezetimibe assigned lerodalcibep-liga … Institute and professor of medicine at the University … important addition to our treatment options.” The company … 47;recruiting trials, guidelines Clinical Guidance, Healio CME, FDA news …

  • Check your medicine cabinets, drawers and kitchens for these 4 recalls 14 Dec 2025 13:43 GMT

    … and Drug Administration. According to the FDA, the New Jersey-based Glenmark Pharmaceuticals … they had “traces of ezetimibe (a drug used to treat high cholesterol … recalled Ziac tablets in their medicine cabinets, they should contact a …

  • Urgent Blood Pressure Drug Recall: Is Your Ziac Contaminated? 12 Dec 2025 23:12 GMT

    drug after quality control testing detected ezetimibe in some of the pills … . “Pharmaceutical companies can develop many different drugs in … doctor to break it down.  “Ziac is a combination pill … continue on with their treatment without interruption.” 3 …

  • Warning issued by FDA for widely used blood-pressure drug 11 Dec 2025 04:03 GMT

    drug: ezetimibe, a medication used to treat high cholesterol. “Driven by economic forces, pharmaceutical … taking Ziac, since stopping treatment suddenly can lead to a … : September 24, 2025 Source: FDA Enforcement Report Chlorpromazine Hydrochloride Tablets …

  • Popular blood pressure tablets recalled over cross contamination fears with another drug 10 Dec 2025 11:48 GMT

    … cross-contaminated with another drug. Glenmark Pharmaceuticals Inc. in the … presence of ezetimibe,” which is a drug used to treat … health consequences”. The affected pills are distributed in 2 … FDA did not state what patients should do if their medication

  • FDA Recalls Blood Pressure Medication Nationwide—Over 11,000 Bottles Affected 10 Dec 2025 17:36 GMT

    … .S. Food and Drug Administration (FDA) just announced a … Manufactured by Glenmark Pharmaceuticals Limited, the recalled medications include lot codes … showed traces of ezetimibe, a drug used to treat … III, meaning the recalled pills are "not likely …

Satisfied with the content?

Continue to create your account.